Home > Search: Nasolide (Removed from Market)

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Nasolide (Removed from Market) All Topic Areas 1 - 10 of 52  more >> Flunisolide Nasal Inhalation Nasarel Nasolide (Removed from Market) Research Cerivastatin - Withdrawn From The Market Baycol - Withdrawn From The Market Spread of the tumor if it is not completely removed New Caledonia Tragacanth Goat's Thorn News 1 - 5 of 1013  more >> To Settle Suit, Maker Agrees to Withdraw Growth Drug New York Times - Wed, 07 Mar 2007 02:58 EST FDA Pulls 15 Migraine Drugs off Market WebMD - Fri, 02 Mar 2007 01:00 EST NYT Examines 'Gray Market' For In-Home Long-Term Care Aides MedicalNewsToday - Mon, 05 Mar 2007 10:00 EST FDA Pulls 15 Migraine Drugs off Market WebMD - Thu, 01 Mar 2007 12:00 EST Moscow Bird Flu From A Single Market MedicalNewsToday - Sun, 18 Feb 2007 08:00 EST Clinical Trials 1 - 5 of 252  more >> Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery ClinicalTrials.gov Identifier: NCT00217711 - Active, not recruiting Colorectal Cancer Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery ClinicalTrials.gov Identifier: NCT00305825 - Active, not recruiting Breast Cancer Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery ClinicalTrials.gov Identifier: NCT00416507 - Active, not recruiting Pancreatic Cancer Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery ClinicalTrials.gov Identifier: NCT00227734 - Active, not recruiting Colorectal Cancer PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery ClinicalTrials.gov Identifier: NCT00365053 - Active, not recruiting Malignant Mesothelioma

GoldBambooTM Your Integrative Health and Wellness Resource December 2, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.